KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Income from Continuing Operations (2016 - 2026)

AbbVie has reported Income from Continuing Operations over the past 14 years, most recently at 1815000000.0 for Q4 2025.

  • Quarterly Income from Continuing Operations rose 7991.3% to 1815000000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 4233000000.0 through Dec 2025, down 1.24% year-over-year, with the annual reading at 4233000000.0 for FY2025, 1.24% down from the prior year.
  • Income from Continuing Operations was 1815000000.0 for Q4 2025 at AbbVie, up from 188000000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 4493000000.0 in Q1 2022 and troughed at 97000000.0 in Q1 2023.
  • The 5-year median for Income from Continuing Operations is 1468500000.0 (2024), against an average of 1822400000.0.
  • Year-over-year, Income from Continuing Operations skyrocketed 10544.74% in 2021 and then crashed 102.79% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 4045000000.0 in 2021, then plummeted by 38.89% to 2472000000.0 in 2022, then crashed by 66.67% to 824000000.0 in 2023, then crashed by 102.79% to 23000000.0 in 2024, then surged by 7991.3% to 1815000000.0 in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Income from Continuing Operations are 1815000000.0 (Q4 2025), 188000000.0 (Q3 2025), and 941000000.0 (Q2 2025).